86 related articles for article (PubMed ID: 1538168)
1. Empiric use of vancomycin in the febrile neutropenic patient.
Cohen J
J Infect Dis; 1992 Mar; 165(3):591. PubMed ID: 1538168
[No Abstract] [Full Text] [Related]
2. Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation.
D'Antonio D; Staniscia T; Piccolomini R; Fioritoni G; Rotolo S; Parruti G; Di Bonaventura G; Manna A; Savini V; Fiorilli MP; Di Giovanni P; Francione A; Schioppa F; Romano F
Chemotherapy; 2004 Jun; 50(2):81-7. PubMed ID: 15211082
[TBL] [Abstract][Full Text] [Related]
3. Enterococcus faecium sensitive to teicoplanin but not vancomycin.
Wilson AP; Felmingham D; Robbins M; Chopra R
J Hosp Infect; 1991 Aug; 18(4):322-4. PubMed ID: 1682372
[No Abstract] [Full Text] [Related]
4. Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin.
Dompeling EC; Donnelly JP; Deresinski SC; Feld R; Lane-Allman EF; De Pauw BE
Eur J Cancer; 1996 Jul; 32A(8):1332-9. PubMed ID: 8869095
[TBL] [Abstract][Full Text] [Related]
5. Do low vancomycine serum levels predict failures of vancomycine therapy in neutropenic cancer patients?
Netriová J; Hal'ko J; Studená-Mrázová M; Kukucková E; Stopková K; Kral'ovicová K; Demitrovicová A; Grausová S; Krupová I; Trupl J; Krcméry V
Bratisl Lek Listy; 1996 Nov; 97(11):680-3. PubMed ID: 9117433
[TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
[TBL] [Abstract][Full Text] [Related]
7. Gram-positive infections in neutropenic patients: glycopeptide antibiotic choice.
Menichetti F
J Antimicrob Chemother; 1992 Apr; 29(4):461-3. PubMed ID: 1535070
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ
Clin Infect Dis; 2006 Mar; 42(5):597-607. PubMed ID: 16447103
[TBL] [Abstract][Full Text] [Related]
9. A therapeutic benefit of daptomycin against glycopeptide-resistant gram-positive cocci bloodstream infections under neutropenia.
Matsuda K; Koya J; Toyama K; Ikeda M; Arai S; Nakamura F; Okugawa S; Moriya K; Kurokawa M
J Infect Chemother; 2017 Nov; 23(11):788-790. PubMed ID: 28743428
[TBL] [Abstract][Full Text] [Related]
10. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer.
Borja J; Gratacós L; García-Barbal J
J Infect Dis; 1994 Nov; 170(5):1344-5. PubMed ID: 7963743
[No Abstract] [Full Text] [Related]
12. Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.
Chaftari AM; Hachem R; Jordan M; Garoge K; Al Hamal Z; El Zakhem A; Viola GM; Granwehr B; Mulanovich V; Gagel A; Reitzel R; Yousif A; Jiang Y; Raad I
Antimicrob Agents Chemother; 2016 Jan; 60(1):239-44. PubMed ID: 26482312
[TBL] [Abstract][Full Text] [Related]
13. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
14. Bacteraemia in neutropenic patients.
O'Connell B; Daly PA; McCann SR; Keane CT
Ir Med J; 1993; 86(6):203-5. PubMed ID: 8106229
[TBL] [Abstract][Full Text] [Related]
15. Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children.
Henwick S; Koehler M; Patrick CC
Clin Infect Dis; 1993 Oct; 17(4):667-71. PubMed ID: 8268348
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
King EA; McCoy D; Desai S; Nyirenda T; Bicking K
J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
[TBL] [Abstract][Full Text] [Related]
17. Bacteremia due to viridans streptococci in neutropenic patients.
Rolston KV; Elting LS; Bodey GP
Am J Med; 1995 Oct; 99(4):450. PubMed ID: 7573114
[No Abstract] [Full Text] [Related]
18. Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child.
Skogen PG; Kolmannskog S; Bergh K
Clin Microbiol Infect; 2001 Jan; 7(1):39-42. PubMed ID: 11284946
[No Abstract] [Full Text] [Related]
19. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern.
Butt T; Afzal RK; Ahmad RN; Salman M; Mahmood A; Anwar M
J Ayub Med Coll Abbottabad; 2004; 16(1):18-22. PubMed ID: 15125174
[TBL] [Abstract][Full Text] [Related]
20. New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients.
Labriola L; Jadoul M
Nephrol Dial Transplant; 2008 Jul; 23(7):2431-2; author reply 2432-3. PubMed ID: 18424462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
